Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).
OBJECTIVE
To correlate oral ketoconazole absorption with gastric acid secretion in patients with the acquired immunodeficiency syndrome (AIDS).


METHODS
Prospective measurement of maximal acid output and oral ketoconazole absorption with and without 0.1-N hydrochloric acid.


METHODS
Hospital in-patients in university medical center.


METHODS
Ten consecutive male patients with AIDS.


METHODS
Maximal acid output was determined after pentagastrin stimulation in all patients. Serum ketoconazole levels were measured the day after ingestion of a 200-mg ketoconazole tablet in the fasted state. On the final day, ketoconazole was ingested with 200 mL of 0.1-N hydrochloric acid.


RESULTS
Maximal acid output was below 15 mEq/h in 7 of 10 patients. In all 7, the area under the serum ketoconazole concentration-time curve was below normal (1.4 +/- 0.9 mg/h.L; mean +/- SE), and absorption was normalized by hydrochloric acid (9.9 +/- mg/h.L). Two of three patients with maximal acid outputs above 15 mEq/h had normal ketoconazole absorption (15.1 +/- 6.7 mg/h.L).


CONCLUSIONS
The bioavailability of oral ketoconazole is reduced in patients with AIDS, largely as a result of gastric hypochlorhydria. Ketoconazole tablets should therefore be given with acid in these patients.
State University of New York Health Science Center, Brooklyn.
G
G
Lake-Bakaar
W
W
Tom
D
D
Lake-Bakaar
N
N
Gupta
S
S
Beidas
M
M
Elsakr
E
E
Straus
D000163:Acquired Immunodeficiency Syndrome / Q000378:metabolism*; D000328:Adult; D005744:Gastric Acid / Q000378:metabolism*; D006801:Humans; D006851:Hydrochloric Acid / Q000494:pharmacology; D007408:Intestinal Absorption / Q000187:drug effects; D007654:Ketoconazole / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged
D006851:Hydrochloric Acid; D007654:Ketoconazole